Marc Denayer Email & Phone Number
Head Pharmacovigilance @ Agomab Therapeutics
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Marc Denayer Location
- Leuven, Flanders, BE
Marc Denayer Work
- Head Pharmacovigilance @ (December 2025 - Present)
- Head of Pharmacovigilance, Estetra SRL, a wholly owned subsidiary of Gedeon Richter Plc @ (June 2024 - December 2025)
- Head of Pharmacovigilance @ (June 2021 - June 2024)
- Global Head Drug Safety and Medical Affairs @ (December 2015 - June 2021)
- Medical Director @ MSD Belgium bvba/sprl (October 2014 - December 2015)
- Member of the Board of Directors @ (March 2009 - April 2014)
- Vice-President Pharmacovigilance and Medical Compliance @ Janssen-Cilag Europe, Middle-East & Africa (May 2008 - April 2014)
- EMEA Head Pharmacovigilance and Medical Compliance @ Janssen-Cilag Europe, Middle-East & Africa (March 2005 - May 2008)
- Senior Director Medical Affairs @ Janssen-Cilag Europe, Middle-East & Africa (June 2001 - March 2005)
- Manager Medical Affairs @ (September 2000 - June 2001)
- Associate Director, International Pharmacovigilance @ (March 1998 - September 2000)
- Head, Clinical Safety – Vaccines @ SmithKline Beecham Biologicals, Rixensart, Belgium (January 1990 - March 1998)
- Academic Assistant @ Institute of Hygiene, Epidemiology Unit (March 1987 - March 1990)
Marc Denayer Education
- Fellow of Belgian College of Pharmaceutical Medicine
Physician Specialist in Pharmaceutical Medicine
2001-2017 - Faculteit Geneeskunde KU Leuven Faculty of Medicine
Medical Doctor
1979-1986
Marc Denayer Skills
- Biotechnology
- Capability Development
- Clinical Research
- Cost Reduction Solutions
- Driving Business Growth
- Drug Safety
- Epidemiology
- Evidence-based Management
- Evidence-based Medicine
- GCP
- Goal Oriented
- Good Clinical Practice (GCP)
- High Performance Teams
- Knowledge Sharing
- Leading transformational change
- Life Sciences
- Medical Affairs
- Medicine
- Networking
- Oncology
- Organizational Development
- People Development
- Pharmaceutical Industry
- Pharmacovigilance
- Process Improvement
- Quality Management
- Regulatory Affairs
- Risk Management
- Therapeutic Areas
- Vaccines
- Marketing
- Evidence Based Management
- Management
- Project Management
- Evidence Based Medicine
- Microsoft Word
- PowerPoint
- Social Media
- Clinical Trials
- Good Clinical Practice Gcp
- Good Clinical Practice
Marc Denayer Summary
- Marc Denayer, based in Leuven, Flanders, BE, is currently a Head Pharmacovigilance at Agomab. Marc Denayer brings experience from previous roles at Richter Gedeon Nyrt. / Magyarország, Mithra, Oxurion NV and MSD Belgium bvba/sprl. Marc Denayer holds a 2001 - 2017 Physician Specialist in Pharmaceutical Medicine @ Fellow of Belgian College of Pharmaceutical Medicine. With a robust skill set that includes Biotechnology, Capability Development, Clinical Research, Cost Reduction Solutions, Driving Business Growth and more. Marc Denayer has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Marc Denayer?
Find contact details for 700 million professionals.
Top Agomab Therapeutics Employees
Imme van der Taelen
Head of Development
Mechelen, BE
Philippe Wiesel
Chief Medical Officer
Arlington, MA, US
Remco van Den Burg
Head of Quality
Amsterdam, NH, NL
Geert Winnen
IMP Supplies Management
Antwerp, BE
Marc Denayer
Head Pharmacovigilance
Leuven, Flanders, BE
Malene Watzinger
Head of Preclinical Safety
Pantin, FR
Ellen Jansen
Head of Clinical Operations
Antwerp, BE
Andrea Sáez Borderías
Chief Development Officer
Barcelona, CT, ES
Ellen Lefever
General Counsel
Antwerp, BE
Andreea Vasilachi
Head of FP and A
Leuven, Flanders, BE
Tim Knotnerus
CEO
Amsterdam, NH, NL
Christine Rudolph
Sr. Director, Early Commercial Lead
Dresden, SN, DE
Kirsten Eisenloeffel
Head of Procurement
Netherlands
Hannah Dams
Corporate Controller
Antwerp, BE
Xavier van Rillaer
Head of Finance and Controlling
Mechelen, BE
Mirjam Bollema
Owner
Netherlands
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co